Changes

no edit summary
Line 166: Line 166:  
!Gene; Genetic Alteration!!Pathway!!Pathophysiologic Outcome
 
!Gene; Genetic Alteration!!Pathway!!Pathophysiologic Outcome
 
|-
 
|-
|<span class="blue-text">EXAMPLE:</span> BRAF and MAP2K1; Activating mutations
+
|<span class="blue-text">EXAMPLE:</span> ''BRAF'' and ''MAP2K1''; Activating mutations
 
|<span class="blue-text">EXAMPLE:</span> MAPK signaling
 
|<span class="blue-text">EXAMPLE:</span> MAPK signaling
 
|<span class="blue-text">EXAMPLE:</span> Increased cell growth and proliferation
 
|<span class="blue-text">EXAMPLE:</span> Increased cell growth and proliferation
 
|-
 
|-
|<span class="blue-text">EXAMPLE:</span> CDKN2A; Inactivating mutations
+
|<span class="blue-text">EXAMPLE:</span> ''CDKN2A''; Inactivating mutations
 
|<span class="blue-text">EXAMPLE:</span> Cell cycle regulation
 
|<span class="blue-text">EXAMPLE:</span> Cell cycle regulation
 
|<span class="blue-text">EXAMPLE:</span> Unregulated cell division
 
|<span class="blue-text">EXAMPLE:</span> Unregulated cell division
 
|-
 
|-
|<span class="blue-text">EXAMPLE:</span> KMT2C and ARID1A; Inactivating mutations
+
|<span class="blue-text">EXAMPLE:</span> ''KMT2C'' and ''ARID1A''; Inactivating mutations
 
|<span class="blue-text">EXAMPLE:</span> Histone modification, chromatin remodeling
 
|<span class="blue-text">EXAMPLE:</span> Histone modification, chromatin remodeling
 
|<span class="blue-text">EXAMPLE:</span> Abnormal gene expression program
 
|<span class="blue-text">EXAMPLE:</span> Abnormal gene expression program